首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
secondary malignant tumor of hilar lymph node相关文献:
Selective Mediastinal Lymph Node Dissection Strategy for Clinical T1N0 Invasive Lung Cancer: A Prospective, Multicenter, Clinical Trial.
Zhang Y, Deng C, Zheng Q, Qian B, Ma J, Zhang C, Jin Y, Shen X, Zang Y, Guo Y, Fu F, Li H, Zheng S, Wu H, Huang Q, Wang S, Liu Q, Ye T, Sun Y, Zhang Y, Xiang J, Hu H, Li Y, Chen H.
J Thorac Oncol. 2023 Jul;18(7):931-939. doi: 10.1016/j.jtho.2023.02.010. Epub 2023 Feb 24.
PMID:36841542
Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma.
Liu ZP, Zhang QY, Chen WY, Huang YY, Zhang YQ, Gong Y, Jiang Y, Bai J, Chen ZY, Dai HS.
J Gastrointest Surg. 2022 May;26(5):1030-1040. doi: 10.1007/s11605-021-05211-x. Epub 2022 Jan 1.
PMID:34973138
Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?
Kumazu Y, Hasegawa S, Hayashi T, Yamada T, Watanabe H, Hara K, Shimoda Y, Nakazono M, Nagasawa S, Rino Y, Masuda M, Ogata T, Oshima T, Yoshikawa T.
Eur J Surg Oncol. 2023 Jan;49(1):76-82. doi: 10.1016/j.ejso.2022.07.008. Epub 2022 Jul 9.
PMID:35868951
Anatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature.
Campi R, Minervini A, Mari A, Hatzichristodoulou G, Sessa F, Lapini A, Sessa M, Gschwend JE, Serni S, Roscigno M, Carini M.
Expert Rev Anticancer Ther. 2017 Mar;17(3):235-246. doi: 10.1080/14737140.2017.1285232. Epub 2017 Feb 6.
PMID:28103449
[The technique of thoracic lymph node dissection].
Oguzhan S, Mese M, Schirren M, Baladov M, Schirren J.
Chirurg. 2019 Dec;90(12):966-973. doi: 10.1007/s00104-019-01032-6.
PMID:31549196
Endobronchial ultrasound sonographic characteristics of mediastinal lymph node in the evaluation of lung cancer.
Pattnaik M, Patra JK, Jha OK.
Monaldi Arch Chest Dis. 2023 Sep 5;94(2). doi: 10.4081/monaldi.2023.2662.
PMID:37675922
Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer.
Fukui T, Kato K, Okasaka T, Kawaguchi K, Fukumoto K, Nakamura S, Hakiri S, Ozeki N, Yokoi K.
Gen Thorac Cardiovasc Surg. 2017 Nov;65(11):640-645. doi: 10.1007/s11748-017-0827-4. Epub 2017 Sep 2.
PMID:28866794
Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma.
Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Conci S, Valdegamberi A, Sandri M, Iacono C.
HPB (Oxford). 2011 Apr;13(4):240-5. doi: 10.1111/j.1477-2574.2010.00277.x. Epub 2011 Jan 28.
PMID:21418129
Invasion category-oriented lymph node metastases of cholangiocarcinoma and the prognostic impact.
Kobayashi S, Wada H, Tomokuni A, Takahashi H, Gotoh K, Sakon M, Mori M, Doki Y, Eguchi H.
Langenbecks Arch Surg. 2020 Nov;405(7):989-998. doi: 10.1007/s00423-020-01955-3. Epub 2020 Aug 18.
PMID:32812064
Overestimation of contralateral hilar lymph node metastasis in non-metastatic non-small cell lung cancer and its predictive model: HAM.
Hou Z, Lin X, Dong B, Lin Z, Zhang Y, Liu X, Wu C, Xu Q, Wang Y, Chen K, Li Q, Chen M.
Radiother Oncol. 2024 Dec;201:110575. doi: 10.1016/j.radonc.2024.110575. Epub 2024 Oct 10.
PMID:39395668
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3